Cargando…
Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study
BACKGROUND: Haematopoietic stem-cell transplantation (HSCT) recipients are considered at high risk of poor outcomes after COVID-19 on the basis of their immunosuppressed status, but data from large studies in HSCT recipients are lacking. This study describes the characteristics and outcomes of HSCT...
Autores principales: | Sharma, Akshay, Bhatt, Neel S, St Martin, Andrew, Abid, Muhammad Bilal, Bloomquist, Jenni, Chemaly, Roy F, Dandoy, Christopher, Gauthier, Jordan, Gowda, Lohith, Perales, Miguel-Angel, Seropian, Stuart, Shaw, Bronwen E, Tuschl, Eileen E, Zeidan, Amer M, Riches, Marcie L, Shah, Gunjan L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816949/ https://www.ncbi.nlm.nih.gov/pubmed/33482113 http://dx.doi.org/10.1016/S2352-3026(20)30429-4 |
Ejemplares similares
-
COVID-19 in Hematopoietic Cell Transplant Recipients: A CIBMTR Study
por: Sharma, Akshay, et al.
Publicado: (2021) -
COVID-19 in Pediatric Hematopoietic Cell Transplant Recipients: A CIBMTR Study
por: Bhatt, Neel S., et al.
Publicado: (2021) -
COVID-19 and Hematopoietic Cell Transplantation Center-Specific Survival Analysis: Can We Adjust for the Impact of the Pandemic? Recommendations of the COVID-19 Task Force of the 2020 Center for International Blood and Marrow Transplantation Research Center Outcomes Forum
por: Wingard, John R., et al.
Publicado: (2021) -
574. De-escalation of Broad Spectrum Antibiotics during Cytokine Release Syndrome with Haploidentical Hematopoietic Stem Cell Transplantation
por: Schiffer, Molly, et al.
Publicado: (2020) -
Attenuated Novel SARS Coronavirus 2 Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient on Ruxolitinib
por: Foss, Francine M., et al.
Publicado: (2020)